GPC-20X

N/A

Report date: 2025/06/11 11:24:18

Base Information

Drug NameGPC-20X
Drug Alias NameCXCR4 receptor antagonist/G protein coupled receptor X2 (GPCRX2) antagonist (GPCR Therapeutics)
ClassificationBiologics
Mechanisms of ActionT lymphocytes stimulantsImmunostimulantsC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGPCR Therapeutics USA Inc
China Registration ClassN/A

Develop Information

Active CompaniesGPCR Therapeutics USA Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A